Pentobarbital will lower the extent or effect of fentanyl transmucosal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Carefully. Coadministration of fentanyl with CYP3A4 inducers could lead to your decrease in fentanyl plasma concentrations, not enough efficacy or, quite possibly, enhancement of a withdrawal syndrome in the patient https://johnnyh800tla0.wikicorrespondent.com/user